SRPT vs STEM · rev $1.90B vs rev $144.6M
Sarepta Therapeutics Inc (SRPT) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
SRPT currently screens at market cap $2.34B. STEM currently screens at market cap $82.1M.
Not investment advice. Open the SRPT and STEM stock pages for the full models.
Not investment advice.